ATE472731T1 - Verfahren um die anwesenheit von krebs in einer probe zu bestimmen durch nachweis der expression eines ssx-2 gens und peptid davon - Google Patents

Verfahren um die anwesenheit von krebs in einer probe zu bestimmen durch nachweis der expression eines ssx-2 gens und peptid davon

Info

Publication number
ATE472731T1
ATE472731T1 AT99930755T AT99930755T ATE472731T1 AT E472731 T1 ATE472731 T1 AT E472731T1 AT 99930755 T AT99930755 T AT 99930755T AT 99930755 T AT99930755 T AT 99930755T AT E472731 T1 ATE472731 T1 AT E472731T1
Authority
AT
Austria
Prior art keywords
ssx
peptide
cancer
gene
expression
Prior art date
Application number
AT99930755T
Other languages
English (en)
Inventor
Ozlem Tureci
Ugur Sahin
Michael Pfreundschuh
Georg Rammensee
Stefan Stevanovic
Yao-Tseng Chen
Ali Gure
Lloyd Old
Original Assignee
Ludwig Inst For Cancer Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst For Cancer Res Ltd filed Critical Ludwig Inst For Cancer Res Ltd
Application granted granted Critical
Publication of ATE472731T1 publication Critical patent/ATE472731T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82—Translation products from oncogenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99930755T 1998-06-26 1999-06-25 Verfahren um die anwesenheit von krebs in einer probe zu bestimmen durch nachweis der expression eines ssx-2 gens und peptid davon ATE472731T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/105,839 US6287756B1 (en) 1997-05-05 1998-06-26 Methods for determining presence of cancer in a sample by determining expression of an SSX gene
PCT/US1999/014493 WO2000000824A1 (en) 1998-06-26 1999-06-25 Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof

Publications (1)

Publication Number Publication Date
ATE472731T1 true ATE472731T1 (de) 2010-07-15

Family

ID=22308065

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99930755T ATE472731T1 (de) 1998-06-26 1999-06-25 Verfahren um die anwesenheit von krebs in einer probe zu bestimmen durch nachweis der expression eines ssx-2 gens und peptid davon

Country Status (10)

Country Link
US (1) US6287756B1 (de)
EP (1) EP1090294B1 (de)
JP (1) JP3572316B2 (de)
KR (1) KR20010089128A (de)
CN (1) CN1315000A (de)
AT (1) ATE472731T1 (de)
AU (1) AU745777B2 (de)
CA (1) CA2334914C (de)
DE (1) DE69942544D1 (de)
WO (1) WO2000000824A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800730B1 (en) * 1998-10-02 2004-10-05 Ludwig Institute For Cancer Research Isolated peptides which bind to MHC class II molecules, and uses thereof
EP1252309A2 (de) 2000-01-28 2002-10-30 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Mhc klasse ii restringierte t-zellepitope des krebsantigens ny-eso-1
EP2278024A1 (de) * 2000-04-28 2011-01-26 Mannkind Corporation Antigener peptide von NY-ESO-1 und deren verwendung als impfstoffe gegen Tumor
AU2002360350A1 (en) * 2001-11-08 2003-05-19 The Burnham Institute Peptides that home to tumor lymphatic vasculature and methods of using same
US7192921B2 (en) 2001-11-08 2007-03-20 The Burnham Institute Peptides that home to tumor lymphatic vasculature and methods of using same
US6896843B2 (en) 2002-08-30 2005-05-24 Kimberly-Clark Worldwide, Inc. Method of making a web which is extensible in at least one direction
JP2005537800A (ja) * 2002-09-06 2005-12-15 マンカインド コーポレイション エピトープ配列
US7178491B2 (en) * 2003-06-05 2007-02-20 Caterpillar Inc Control system and method for engine valve actuator
US20050118186A1 (en) * 2003-06-17 2005-06-02 Chih-Sheng Chiang Combinations of tumor-associated antigens in compositions for various types of cancers
DE602004031116D1 (de) * 2003-07-22 2011-03-03 Ludwig Inst For Cancer Res New York Von hla-klasse-ii-molekülen präsentierte ssx-2-peptide
MX2007008013A (es) * 2004-12-29 2008-02-07 Mannkind Corp Metodos para producir, mejorar y sostener respuestas inmunes contra epitopos i-restringidos clase mhc por propositos profilacticos o terapeuticos.
WO2006105043A2 (en) * 2005-03-28 2006-10-05 Dendritic Nanotechnologies, Inc. Janus dendrimers and dendrons
AU2006259220C1 (en) 2005-06-17 2013-05-16 Mannkind Corporation Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
US7635753B2 (en) 2007-02-19 2009-12-22 Wisconsin Alumni Research Foundation Prostate cancer and melanoma antigens
WO2011130742A2 (en) 2010-04-16 2011-10-20 Wisconsin Alumni Research Foundation Diagnostic evaluation of antibody responses to commonly recognized prostate cancer-associated antigens
CN102251035B (zh) * 2011-07-05 2013-01-23 北京大学人民医院 基于ssx-2基因辅助诊断多发性骨髓瘤患者的定量检测试剂盒
CN104004822B (zh) * 2013-02-27 2018-08-07 霍克克 Ssx2ip在预测或诊断肿瘤转移中的应用
WO2016054079A1 (en) 2014-09-29 2016-04-07 Zyomed Corp. Systems and methods for blood glucose and other analyte detection and measurement using collision computing
US9554738B1 (en) 2016-03-30 2017-01-31 Zyomed Corp. Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing
CN110950949B (zh) * 2018-09-26 2022-04-05 香雪生命科学技术（广东）有限公司 一种识别ssx2抗原的t细胞受体
CN110218774A (zh) * 2019-06-27 2019-09-10 杭州艾迪康医学检验中心有限公司 用于检测syt-ssx融合基因的引物、试剂盒和方法
WO2024233388A2 (en) * 2023-05-05 2024-11-14 Memorial Sloan-Kettering Cancer Center Sarcoma cancer vaccines and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804381A (en) * 1996-10-03 1998-09-08 Cornell Research Foundation Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof
KR960700739A (ko) * 1993-03-05 1996-02-24 카린 이스텀 Hla-a2. 1 결합 펩티드 및 그의 용도(hla-a2. 1 binding peptides and their uses)
GB9414580D0 (en) * 1994-07-19 1994-09-07 Cancer Res Campaign Tech Materials and methods relating to the diagnosis of synovial sarcomas
US5698396A (en) * 1995-06-07 1997-12-16 Ludwig Institute For Cancer Research Method for identifying auto-immunoreactive substances from a subject
US6025191A (en) 1995-06-07 2000-02-15 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which encode a melanoma specific antigen and uses thereof
US5840568A (en) * 1995-06-07 1998-11-24 Ludwig Institute For Cancer Research Hodgkin's disease associated molecules and uses thereof
US6291658B1 (en) * 1997-05-05 2001-09-18 Ludwig Institute For Cancer Research Isolated nucleic acid molecules encoding SSX family members and thereof
US5888751A (en) * 1997-07-15 1999-03-30 Ludwig Institute For Cancer Research Method for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells

Also Published As

Publication number Publication date
KR20010089128A (ko) 2001-09-29
CN1315000A (zh) 2001-09-26
JP2002519013A (ja) 2002-07-02
EP1090294A1 (de) 2001-04-11
US6287756B1 (en) 2001-09-11
EP1090294A4 (de) 2003-02-26
WO2000000824A1 (en) 2000-01-06
CA2334914C (en) 2010-10-19
DE69942544D1 (de) 2010-08-12
JP3572316B2 (ja) 2004-09-29
CA2334914A1 (en) 2000-01-06
AU4722199A (en) 2000-01-17
EP1090294B1 (de) 2010-06-30
AU745777B2 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
ATE472731T1 (de) Verfahren um die anwesenheit von krebs in einer probe zu bestimmen durch nachweis der expression eines ssx-2 gens und peptid davon
DE60223561D1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
DE60041355D1 (de) Verfahren zur detektion von erkrankungen
ATE515575T1 (de) Verfahren und sonden für den nachweis von krebs
ATE271691T1 (de) Verfahren zum nachweis der effektivität einer krebstherapie
ATE504660T1 (de) Einstufige oligochromatographische vorrichtung und verfahren zu ihrer verwendung
ATE445841T1 (de) Verfahren zur spezifischen detektion von tumorzellen und ihren vorstufen in gebärmutterhalsabstrichen durch simultane messung von mindestens 2 verschiedenen molekularen markern
ATE385259T1 (de) Verfahren zum nachweis von influenza a/b-viren in speichel
DE60028361D1 (de) Verfahren und zusammensetzungen zur karzinomdiagnose
ATE508360T1 (de) Verfahren, vorrichtungen und computerprogramme zum verifizieren der integrität einer sonde
ATE336591T1 (de) Nachweisverfahren für kurze sequenzvarianten
DE602005008427D1 (de) Verfahren zur erfassung von wasserzeichen
ATE206211T1 (de) Linker-system zum aktivieren von oberflächen für die biokonjugation und verfahren zu ihrer verwendung
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
DE69632252D1 (de) Verfahren zur erkennung von klonalen populationen von transformierten zellen in einer genomisch heterogenen zellulären probe
ATE397098T1 (de) Verfahren zur diagnostik von eierstock endometriose
ATE523773T1 (de) Verfahren und installation zur bestimmung der rheologischen eigenschaften eines fluids sowie entsprechendes identifizierungsverfahren
DE69604051D1 (de) Verfahren zum sensitiven nachweis von reverser transcriptase
ATE379815T1 (de) Verfahren und vorrichtung zum identifizieren einer biologischen probe
ATE408710T1 (de) Nachweis von legionella durch ein pcr und fret verwendendes verfahren
ATE226727T1 (de) Leistungssteigerung von bindungsassays mit verwendung mehr als einer markierungsmittel
DE60142634D1 (de) Erkennung von tumor-spezifischen genprodukten bei krebs
ATE412182T1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DK0983510T3 (da) Genkendelse af tumorspecifikke genprodukter i cancer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1090294

Country of ref document: EP